Profile
Peter Jarrett is Chief Technical Officer at Ocular Therapeutix, Inc. since 2024 and has been with the company since 2007.
Formerly, Dr. Jarrett was Head-Research & Development at Wyeth Holdings LLC, Vice President-Research & Development at Focal, Inc. from 1993 to 2001, and Vice President-Biomaterials Research & Development at Genzyme Corp.
from 2001 to 2007.
Education includes undergraduate studies at Connecticut College and a doctorate from The Institute of Materials Science.
Peter Jarrett active positions
| Companies | Position | Start |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Former positions of Peter Jarrett
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 2007-06-30 |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Chief Tech/Sci/R&D Officer | 2000-12-31 |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Chief Tech/Sci/R&D Officer | - |
Training of Peter Jarrett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Process Industries |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Connecticut College
Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Institute of Materials Science
The Institute of Materials Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Peter Jarrett
















